MedTrace Logo

Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

NCT01541358 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2017-06-14

Study results available
· View outcomes & findings →

Summary

This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone cancer

Conditions

  • Bone Cancer

Interventions

RADIATION

fluorine F 18 sodium fluoride

Undergo fluorine F 18 sodium fluoride PET/CT scan

PROCEDURE

positron emission tomography/computed tomography

Undergo fluorine F 18 sodium fluoride PET/CT scan

Sponsors & Collaborators

Principal Investigators

  • Andrew Quon · Stanford University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01541358 on ClinicalTrials.gov